Ethics Committee Investigating New York Congressman's Ties to This Australian Biotech

Published: May 18, 2017

Rep. Chris Collins, R-N.Y., faces an investigation from the independent Office of Congressional Ethics for his part in attracting investors to an Australian biotech company.

Collins is Innate Immunotherapuetics's largest shareholding, his stakes worth between $5 and $25 million, and boasted earlier this year about "how many millionaires I've made in Buffalo the past few months," according to The Buffalo News.

Anonymous sources told Buffalo News that investigators have interviewed several investors in the Buffalo area about Collin's role in persuading them to buy the company's stock.

Back to news